W

Withus Pharmaceutical Co Ltd
KOSDAQ:330350

Watchlist Manager
Withus Pharmaceutical Co Ltd
KOSDAQ:330350
Watchlist
Price: 8 640 KRW -1.03% Market Closed
Market Cap: ₩114B

Net Margin

6.1%
Current
Improving
by 0.5%
vs 3-y average of 5.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
6.1%
=
Net Income
₩6.3B
/
Revenue
₩102.1B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
6.1%
=
Net Income
₩6.3B
/
Revenue
₩102.1B

Peer Comparison

Country Company Market Cap Net
Margin
KR
Withus Pharmaceutical Co Ltd
KOSDAQ:330350
114B KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
546.2B USD
Loading...
CH
Roche Holding AG
SIX:ROG
269.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
208.2B GBP
Loading...
CH
Novartis AG
SIX:NOVN
218.2B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
265.4B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.6B USD
Loading...
FR
Sanofi SA
PAR:SAN
94.2B EUR
Loading...

Market Distribution

Higher than 71% of companies in Korea
Percentile
71st
Based on 2 632 companies
71st percentile
6.1%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Withus Pharmaceutical Co Ltd
Glance View

Market Cap
114B KRW
Industry
Pharmaceuticals

Withus Pharmaceutical Co., Ltd. manufactures and sells prescription drugs. The company is headquartered in Seoul, Seoul and currently employs 217 full-time employees. The company went IPO on 2020-07-03. The firm's main products include circulatory agents, musculoskeletal agents, digestive agents, antibiotics and other prescription drugs. And the Company is engaged in contract manufacturing operation(CMO).

Withus Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
6.1%
=
Net Income
₩6.3B
/
Revenue
₩102.1B
What is Withus Pharmaceutical Co Ltd's current Net Margin?

The current Net Margin for Withus Pharmaceutical Co Ltd is 6.1%, which is above its 3-year median of 5.7%.

How has Net Margin changed over time?

Over the last 3 years, Withus Pharmaceutical Co Ltd’s Net Margin has decreased from 8.4% to 6.1%. During this period, it reached a low of 1.7% on Mar 31, 2023 and a high of 10.2% on Mar 31, 2024.

Back to Top